Evidence map›Paper›PMID 26445499›Full record

ArticlePloS one2015

Accuracy of Continuous Glucose Monitoring Measurements in Normo-Glycemic Individuals.

Abimbola A Akintola, Raymond Noordam, Steffy W Jansen, Anton J de Craen, Bart E Ballieux, Christa M Cobbaert, Simon P Mooijaart, Hanno Pijl, Rudi G Westendorp, Diana van Heemst

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advances in laboratory medicine · 2025
    Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Abimbola A AkintolaDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Raymond NoordamDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Steffy W JansenDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Anton J de CraenDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Bart E BallieuxDepartment of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands.
Christa M CobbaertDepartment of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands.
Simon P MooijaartDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Hanno PijlDepartment of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands.
Rudi G WestendorpDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Diana van HeemstDepartment of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe validity of continuous glucose monitoring (CGM) is well established in diabetic patients. CGM is also increasingly used for research purposes in normo-glycemic individuals, but the CGM validity in such individuals is unknown. We studied the accuracy of CGM measurements in normo-glycemic individuals by comparing CGM-derived versus venous blood-derived glucose levels and measures of glycemia and glycemic variability.

methodsIn 34 healthy participants (mean age 65.7 years), glucose was simultaneously measured every 10 minutes, via both an Enlite® CGM sensor, and in venous blood sampled over a 24-hour period. Validity of CGM-derived individual glucose measurements, calculated measures of glycemia over daytime (09:00h-23:00h) and nighttime (23:00h-09:00h), and calculated measures of glycemic variability (e.g. 24h standard deviation [SD]) were assessed by Pearson correlation coefficients, mean absolute relative difference (MARD) and paired t-tests.

resultsThe median correlation coefficient between CGM and venous glucose measurements per participant was 0.68 (interquartile range: 0.40-0.78), and the MARD was 17.6% (SD = 17%). Compared with venous sampling, the calculated measure of glycemia during daytime was 0.22 mmol/L higher when derived from CGM, but no difference was observed during nighttime. Most measures of glycemic variability were lower with CGM than with venous blood sampling (e.g., 24h SD: 1.07 with CGM and 1.26 with venous blood; p-value = 0.004).

conclusionIn normo-glycemic individuals, CGM-derived glucose measurements had good agreement with venous glucose levels. However, the measure of glycemia was higher during the day and most measures of glycemic variability were lower when derived from CGM.

Indexed as

Blood Glucose Self-MonitoringAgedBlood GlucoseBody Mass IndexFemaleHemoglobinsHumansMaleMiddle AgedBlood GlucoseHemoglobins

Identifiers

PMID26445499
PMCPMC4596806
OpenAlexW2220737134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.